Accessibility Menu
aTyr Pharma logo

aTyr Pharma

(NASDAQ) ATYR

Current Price$0.83
Market Cap$81.15M
Since IPO (2015)-100%
5 Year-85%
1 Year-78%
1 Month-16%

aTyr Pharma Financials at a Glance

Market Cap

$81.15M

Revenue (TTM)

$190.00K

Net Income (TTM)

$74.12M

EPS (TTM)

$-0.80

P/E Ratio

-1.04

Dividend

$0.00

Beta (Volatility)

0.77 (Low)

Price

$0.83

Volume

0

Open

$0.82

Previous Close

$0.83

Daily Range

$0.79 - $0.84

52-Week Range

$0.64 - $7.29

ATYR: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About aTyr Pharma

Industry

Biotechnology

Employees

58

CEO

Sanjay S. Shukla, MD

Headquarters

San Diego, CA 92121, US

ATYR Financials

Key Financial Metrics (TTM)

Gross Margin

-118%

Operating Margin

-409%

Net Income Margin

-390%

Return on Equity

-108%

Return on Capital

-98%

Return on Assets

-79%

Earnings Yield

-96.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$81.15M

Shares Outstanding

98.05M

Volume

0

Short Interest

0.00%

Avg. Volume

1.85M

Financials (TTM)

Gross Profit

$1.36M

Operating Income

$77.63M

EBITDA

$76.07M

Operating Cash Flow

$61.99M

Capital Expenditure

$77.00K

Free Cash Flow

$62.06M

Cash & ST Invst.

$78.69M

Total Debt

$12.03M

aTyr Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$394.00K

+96.8%

Gross Margin

0.00%

N/A

Market Cap

$81.15M

N/A

Market Cap/Employee

$1.45M

N/A

Employees

56

N/A

Net Income

$13.96M

+6.7%

EBITDA

$14.40M

+7.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$66.65M

+13.3%

Accounts Receivable

$873.00K

-49.7%

Inventory

$0.00

N/A

Long Term Debt

$10.57M

-12.2%

Short Term Debt

$1.47M

+17.1%

Return on Assets

-78.71%

N/A

Return on Invested Capital

-98.24%

N/A

Free Cash Flow

$12.23M

+7.1%

Operating Cash Flow

$12.20M

+7.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DTILPrecision BioSciences, Inc.
$6.72-4.41%
HYFTMindWalk Holdings Corp.
$1.22+5.17%
MGXMetagenomi, Inc. Common Stock
$1.47+2.08%
ACRVAcrivon Therapeutics, Inc. Common Stock
$1.70+3.66%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$45.69-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.97-0.06%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$75.91+0.01%
IBITiShares Bitcoin Trust
$39.82-0.01%

Questions About ATYR

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.